AstraZeneca’s RSV Antibody May Need More Data Due To Impact Of Maternal Vaccines
Executive Summary
Maternal vaccines may cause first RSV infections to occur when infants are older, requiring increased study of disease patterns and additional dosing data on AstraZeneca/Sanofi’s nirsevimab in older babies.